Pharmacological aspects of concurrent administration of furosemide and skeletal muscle relaxants.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002707:Chlordiazepoxide / Q000494:pharmacology; D003964:Diaphragm; D004231:Diuresis / Q000187:drug effects; D004338:Drug Combinations; D004347:Drug Interactions; D004558:Electric Stimulation; D005260:Female; D005665:Furosemide / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D008297:Male; D009132:Muscles / Q000187:drug effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D009994:Osmolar Concentration; D010791:Phrenic Nerve; D011188:Potassium / Q000097:blood / Q000652:urine; D051381:Rats; D012964:Sodium / Q000097:blood / Q000652:urine; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D004338:Drug Combinations; D003473:Neuromuscular Nondepolarizing Agents; D002707:Chlordiazepoxide; D005665:Furosemide; D012964:Sodium; D013390:Succinylcholine; D011188:Potassium; D014403:Tubocurarine